Kanagawa, Japan

Tsunemichi Hosokawa


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Tokyo, JP (1999)
  • Kanagawa, JP (2000)

Company Filing History:


Years Active: 1999-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tsunemichi Hosokawa: Innovator in Medical Treatments

Introduction

Tsunemichi Hosokawa is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical treatments, particularly in addressing autoimmune diseases and ocular conditions. With a total of 2 patents, his work reflects a commitment to advancing healthcare solutions.

Latest Patents

Hosokawa's latest patents include a method for preventing and treating autoimmune diseases. This innovative approach involves administering an insulin resistance improving substance as an active ingredient, specifically targeting autoimmune diseases excluding type I diabetes. Additionally, he has developed a method for treating ocular hypertension and glaucoma. This method entails locally administering a composition to the eyes of a mammal, which contains an effective amount of a specific compound designed to alleviate these conditions.

Career Highlights

Tsunemichi Hosokawa is associated with Sankyo Company, Limited, where he has been instrumental in research and development. His work has contributed to the advancement of medical treatments that address critical health issues.

Collaborations

Throughout his career, Hosokawa has collaborated with esteemed colleagues, including Toshihiko Fujiwara and Shinichi Kurakata. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Tsunemichi Hosokawa's contributions to medical science through his patents and collaborations highlight his role as a key innovator in the field. His work continues to pave the way for new treatments that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…